These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34248630)

  • 1. MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression.
    Cao X; Zhang Z; Wang Y; Shan W; Wang R; Mao S; Ding S; Pang C; Li B; Zhou J; Guo X; Guo N; Li C; Liang J; Ma W; Liu Y; Zhao L
    Front Pharmacol; 2021; 12():680349. PubMed ID: 34248630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA GAS5 Attenuates Cardiac Electrical Remodeling Induced by Rapid Pacing via the miR-27a-3p/HOXa10 Pathway.
    Xi S; Wang H; Chen J; Gan T; Zhao L
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1.
    Li D; Shen M; Deng X; Bai Y
    Bioengineered; 2022 Apr; 13(4):8982-8993. PubMed ID: 35348441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε.
    Zhu YF; Wang R; Chen W; Cao YD; Li LP; Chen X
    Acta Histochem; 2021 Jan; 123(1):151653. PubMed ID: 33246224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-410-3p facilitates Angiotensin II-induced cardiac hypertrophy by targeting Smad7.
    Jia G; Liang C; Li W; Dai H
    Bioengineered; 2022 Jan; 13(1):119-127. PubMed ID: 34951337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting myocyte-specific enhancer factor 2D contributes to the suppression of cardiac hypertrophic growth by miR-92b-3p in mice.
    Hu ZQ; Luo JF; Yu XJ; Zhu JN; Huang L; Yang J; Fu YH; Li T; Xue YM; Feng YQ; Shan ZX
    Oncotarget; 2017 Nov; 8(54):92079-92089. PubMed ID: 29190899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qishen Yiqi dropping pills improve cardiomyocyte hypertrophy via the lncRNA TINCR/miR-193b-3p/RORA axis.
    Chen L; Pan L; Zhang Y; Chen Y; Su Y; Luo Y; Wu Z; Zheng W; Cai S; Liu X; Wu X
    J Thorac Dis; 2022 Nov; 14(11):4372-4383. PubMed ID: 36524095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure.
    Tian C; Hu G; Gao L; Hackfort BT; Zucker IH
    J Mol Cell Cardiol; 2020 Jun; 143():120-131. PubMed ID: 32370947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway.
    Zhang K; Zhuo H; Guo J; Wang W; Dai R
    Int Heart J; 2024; 65(1):119-127. PubMed ID: 38296564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effects of the miR-129-5p/keap-1/Nrf2 axis on Ang II-induced cardiomyocyte hypertrophy.
    Ye H; Xu G; Zhang D; Wang R
    Ann Transl Med; 2021 Jan; 9(2):154. PubMed ID: 33569456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0010729 regulates hypoxia-induced cardiomyocyte injuries by activating TRAF5 via sponging miR-27a-3p.
    Lei D; Wang Y; Zhang L; Wang Z
    Life Sci; 2020 Dec; 262():118511. PubMed ID: 33010282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
    Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
    J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIF regulates the expression of miR-27a-3p and HOXA10 in bovine endometrial epithelial cells via STAT3 pathway.
    Li Q; Chen Y; Adeniran SO; Qiu Z; Zhao Q; Zheng P
    Theriogenology; 2023 Oct; 210():101-109. PubMed ID: 37490795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p.
    Zou X; Wang J; Tang L; Wen Q
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):482-490. PubMed ID: 31183682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of TUG1 rescues cardiomyocyte hypertrophy through targeting the miR-497/MEF2C axis.
    Zhang G; Ni X
    Open Life Sci; 2021; 16(1):242-251. PubMed ID: 33817315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
    Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
    J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-208a-3p aggravates autophagy through the PDCD4-ATG5 pathway in Ang II-induced H9c2 cardiomyoblasts.
    Wang L; Ye N; Lian X; Peng F; Zhang H; Gong H
    Biomed Pharmacother; 2018 Feb; 98():1-8. PubMed ID: 29241069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.